Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)

NCT01486485 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Injury

Interventions

DRUG: heparinized saline priming group
DRUG: nafamostat infusion after heparinized saline priming

Sponsor

Seoul National University Hospital

Collaborators

[object Object]